CBO expects to be able to provide an estimated range of the budgetary effects of H.R. 1770, the Equitable Community Access to Pharmacist Services Act, by the end of June 2024.

    

The House Committee on the Budget convened a hearing at which Phillip L. Swagel, CBO's Director, testified. This document provides CBO’s answers to questions submitted for the record.

    

As reported by the Senate Committee on Small Business and Entrepreneurship on July 25, 2023

    

As ordered reported by the House Committee on Natural Resources on December 6, 2023

    

The Subcommittee on Health of the House Committee on Energy and Commerce convened a hearing at which Chapin White, CBO’s Director of Health Analysis, testified. This document provides CBO’s answers to questions submitted for the record.